Literature DB >> 23881224

Hypersensitivity pneumonitis: a review and update of histologic findings.

Dianne Grunes1, Mary Beth Beasley.   

Abstract

Hypersensitivity pneumonitis (HSP) is a poorly understood entity typically caused by exposure to an inciting antigen such as fungi, thermophilic bacteria or animal protein. Clinically, HSP is often divided into acute, subacute and chronic forms. While the subacute form is best described from a pathologic standpoint, the pathology of chronic HSP has only been critically evaluated in the past decade and the pathology of acute HSP is poorly described. The aim of this review is to summarise the current knowledge of pathogenetic theories of HSP and to review the current knowledge of the pathology of each stage of HSP and the main entities in the differential diagnosis.

Entities:  

Keywords:  GRANULOMA; LUNG; fibrosis

Mesh:

Substances:

Year:  2013        PMID: 23881224     DOI: 10.1136/jclinpath-2012-201337

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  5 in total

1.  Age-associated B Cells Appear in Patients with Granulomatous Lung Diseases.

Authors:  Swati Phalke; Katja Aviszus; Kira Rubtsova; Anatoly Rubtsov; Briana Barkes; Linda Powers; Brenda Warner; James L Crooks; John W Kappler; Evans R Fernández-Pérez; Lisa A Maier; Nabeel Hamzeh; Philippa Marrack
Journal:  Am J Respir Crit Care Med       Date:  2020-10-01       Impact factor: 21.405

2.  Glutathione peroxidase 3 localizes to the epithelial lining fluid and the extracellular matrix in interstitial lung disease.

Authors:  Andrea C Schamberger; Herbert B Schiller; Isis E Fernandez; Martina Sterclova; Katharina Heinzelmann; Elisabeth Hennen; Rudolf Hatz; Jürgen Behr; Martina Vašáková; Matthias Mann; Oliver Eickelberg; Claudia A Staab-Weijnitz
Journal:  Sci Rep       Date:  2016-07-20       Impact factor: 4.379

Review 3.  Chronic hypersensitivity pneumonitis.

Authors:  Carlos Ac Pereira; Andréa Gimenez; Lilian Kuranishi; Karin Storrer
Journal:  J Asthma Allergy       Date:  2016-09-21

4.  Serum AGE/RAGEs as potential biomarker in idiopathic pulmonary fibrosis.

Authors:  Carlos Machahua; Ana Montes-Worboys; Lurdes Planas-Cerezales; Raquel Buendia-Flores; Maria Molina-Molina; Vanesa Vicens-Zygmunt
Journal:  Respir Res       Date:  2018-11-08

Review 5.  Challenges in the Diagnosis and Management of Fibrotic Hypersensitivity Pneumonitis: A Practical Review of Current Approaches.

Authors:  Teng Moua; Tananchai Petnak; Antonios Charokopos; Misbah Baqir; Jay H Ryu
Journal:  J Clin Med       Date:  2022-03-08       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.